Patent · US Active

Agent for preventing deterioration in vascular endothelial function or improving vascular endothelial function

US9833426B2 · kind B2 · utility

2Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 28, 2013
Grant dateDec 5, 2017
Priority date—
Expiry dateJun 28, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

An agent for enhancing NO production, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient. An agent for preventing or ameliorating vascular endothelial malfunction, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient. An agent for preventing or ameliorating a symptom caused by vascular endothelial malfunction, comprising citrulline or a salt thereof and serine or a salt thereof as an active ingredient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.